81
60
Growth Score 81 in past quarter
-5 pts
Heat Score 60 in past quarter
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1109949
Cell Pathways develops small molecule-based drugs for cancer treatment.
Acquired by 

OSI Pharmaceuticals
About the Company
Cell Pathways develops small molecule-based drugs for cancer treatment. The company has developed an apoptosis technology platform for the development of therapeutic agents for cancer. These can be used in combination with other chemotherapy drugs.
